Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel

The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high...

Full description

Bibliographic Details
Main Authors: Shmuel Stienlauf, Vered Yahalom, Eli Schwartz, Eilat Shinar, Gad Segal, Yechezkel Sidi
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2009-07-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/15/7/08-0796_article
id doaj-8969adbaf6114ab0b04d3f00e522d5b0
record_format Article
spelling doaj-8969adbaf6114ab0b04d3f00e522d5b02020-11-25T01:02:57ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592009-07-011571116111810.3201/eid1507.080796Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, IsraelShmuel StienlaufVered YahalomEli SchwartzEilat ShinarGad SegalYechezkel SidiThe prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.https://wwwnc.cdc.gov/eid/article/15/7/08-0796_articleKeywords: HTLV-1 infectionshuman T-cell lymphotropic virus type 1virusesepidemiologyIsraelemigration and immigration
collection DOAJ
language English
format Article
sources DOAJ
author Shmuel Stienlauf
Vered Yahalom
Eli Schwartz
Eilat Shinar
Gad Segal
Yechezkel Sidi
spellingShingle Shmuel Stienlauf
Vered Yahalom
Eli Schwartz
Eilat Shinar
Gad Segal
Yechezkel Sidi
Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
Emerging Infectious Diseases
Keywords: HTLV-1 infections
human T-cell lymphotropic virus type 1
viruses
epidemiology
Israel
emigration and immigration
author_facet Shmuel Stienlauf
Vered Yahalom
Eli Schwartz
Eilat Shinar
Gad Segal
Yechezkel Sidi
author_sort Shmuel Stienlauf
title Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_short Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_full Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_fullStr Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_full_unstemmed Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_sort epidemiology of human t-cell lymphotropic virus type 1 infection in blood donors, israel
publisher Centers for Disease Control and Prevention
series Emerging Infectious Diseases
issn 1080-6040
1080-6059
publishDate 2009-07-01
description The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.
topic Keywords: HTLV-1 infections
human T-cell lymphotropic virus type 1
viruses
epidemiology
Israel
emigration and immigration
url https://wwwnc.cdc.gov/eid/article/15/7/08-0796_article
work_keys_str_mv AT shmuelstienlauf epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT veredyahalom epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT elischwartz epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT eilatshinar epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT gadsegal epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT yechezkelsidi epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
_version_ 1725203018718117888